Analysis for ROP
- 📈 Growth — 24/30
- 💰 Profitability — 18/20
- 🏦 Financial Health — 14/20
- 💵 Valuation — 12/20
- ⚠️ Risk — 4/10
Summary:
📈 Growth & Financial Trajectory
Across the 8 quarters, Revenues rise from about $1.764B (2024 Q3) to $2.109B (2026 Q2), a roughly 20% uplift. Net income grows from about $462.3M to $1.169B, with a sharp acceleration in 2026 Q2, where Diluted EPS reached $11.62. The trend reflects improving earnings power alongside steady top-line growth.
💰 Margins & Cash Flow
Latest margins remain robust: Gross Margin ≈ 69.7% and Operating Margin ≈ 27.7% in Q2 2026 (gross profit $1.470B on $2.109B revenue; operating income $584.7M). Cash flow remains supportive: Net Cash Flow From Operating Activities was $469.5M in Q2 2026 (and $592.1M continuing in Q2 2025), while investing cash flow was modest (-$16.2M in Q2 2026) and financing outflows were sizeable (-$460.4M), yielding a small overall net flow (-$18M).
🛡️ Balance Sheet & Liquidity
Fundamentally solid, with Assets ~$35.17B, Liabilities ~$16.47B, and Equity ~$18.70B in Q2 2026. Current assets $1.92B vs current liabilities $3.47B creates a near-term liquidity gap (current ratio ≈ 0.55). Noncurrent liabilities stand at $12.999B, supporting a sizable long-run capital base and a healthy equity cushion.
⚠️ Key Drivers & Risks
- Drivers: Diversified industrial portfolio provides resilience; strong FCF generation supports internal investments and returns. * Risks: Cyclicality of industrial markets and macro sensitivity; liquidity tightness suggested by near-term balance-sheet figures could amp up valuation sensitivity during downturns.